So nothing has changed , usual spin , talking to everyone and...

First 5 Last

Share
Profile

Follow
Icarus

4,150 Posts.

59

27/03/19

15:02

Post #: 37901917
Share

Originally posted by DoriansMirror ↑

I listened to the conference this afternoon. Some of what was said included:

Purpose is to put more context around the newsletter

Frustrated about not being able to share with us the names of the companies they are working with and how they are evaluating out technology.

Many additional global partners in conversation with that will follow.

Much stronger position than where we were in October.

No offer of rights (exclusive or otherwise) to any potential partner at this stage.

These companies are putting in a lot of money and time to their own investigations.

The nature of design of trials are much more thorough than in the past. This can give way to particular commercial applications.

Talking to so many companies because product can have relevance to a number of different markets. Trying to talk to multiple companies in each space. Ensure we get traction as soon as we can.

Questions:

Why is a deal taking so long? The companies are very big top tier companies have complex internal processes that are difficult to navigate. Sounds like ti will still take a while.

Why did you believe a deal was imminent in October? Was talking to one particular company that said out tech would be fast-tracked through their internal processes. Is still a much slower process than anticipated.

Are the companies testing efficacy on only one pest? Companies are testing in many different ways. At least one company is focusing on a narrow market. Others taking a more general approach testing multiple crops, etc (This is good because that gives us access to a large number of tests that we don't have to pay for).

Are these companies co-investing with Bio-Gene? Yes. They are paying for all the tests they are currently doing (and bio-gene co-owns the results).

Why can't you name these companies? A contract says so.

Have any potential partners decided to not continue? No. These companies are continuing to test. Everyone is currently on track.

Could you progress to commercialisation on your own? Pretty much, no. Partnership was always the plan and is the best approach.

Expand

So nothing has changed , usual spin , talking to everyone and zero have committed ?

BGT Price at posting: 9.9¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

There are more pages in this discussion • 16 more messages in this thread...

First 5 Last

Add BGT (ASX) to my watchlist

(20min delay)
Last 4.4¢		Change 0.001(2.33%)		Mkt cap ! $8.859M

Open	High	Low	Value	Volume
4.4¢	4.4¢	4.4¢	$5	112

Buyers (Bids)

No.	Vol.	Price($)
1	20000	4.2¢

Sellers (Offers)

Price($)	Vol.	No.
4.5¢	12375	1

View Market Depth

No.	Vol.	Price($)
1	8563	0.044
1	100000	0.039
1	118000	0.038
1	120050	0.037
1	64000	0.029

Price($)	Vol.	No.
0.048	30000	1
0.053	11511	1
0.054	59999	2
0.055	118498	1
0.061	225000	2

Last trade - 10.00am 29/11/2024 (20 minute delay)

BGT (ASX) Chart

So nothing has changed , usual spin , talking to everyone and...

Top Stories

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Buyers (Bids)

Sellers (Offers)